Fund V
Size: EUR 1,500 million
Year: 2003
Investment focus/criteria:
Geographic scope:Nordic Region
Industries:Diversified, special focus on and expertise in healthcare investments
Main focus:Large and medium-sized companies
Key Characteristics:Opportunities for structural transformation, operational improvements, buy & build, emerging market growth, strategic repositioning, international expansion and growth acceleration
Investors:
Investors in Fund V are 60
institutions from 13 countries, e.g. pension funds, banks and
insurance companies.
The Nordic region represents 21% of committed
capital, Europe 33%, the US 33% and rest of the world 13%.
General Partner Board of Directors:
Lynda Elliott
Ged Kelly
Jean Le Creurer
Keith Mackenzie
David Pirouet
Investments:
| Investment year |
Company |
Industry |
Turnover (EUR m)* |
Exit |
|
1999
|
Ahlsell |
HVPAC and electrical wholesaler
|
|
2006
|
|
1999
|
BE Group |
Steel and aluminum products wholesaler
|
|
2006
|
|
1999
|
Reynolds |
Wholesaler of aluminum, copper and brass products
|
|
2005
|
|
2004
|
Aditro |
Business process and software services
|
|
2013
|
|
2004
|
Point International |
Electronic payment solutions
|
|
2011
|
|
2004
|
KappAhl |
Fashion retail chain
|
|
2006
|
|
2004
|
Falck |
Emergency and assistance services
|
|
2011
|
|
2004
|
Bufab |
Fasteners and small parts for general industry
|
|
2014
|
|
2005
|
Plastal |
Automotive plastic components
|
|
2009
|
|
2005
|
Kompan |
Playground equipment manufacturing
|
|
2014
|
|
2005
|
Atos Medical |
Medical devices
|
|
2011
|
|
2005
|
Nycomed |
Pharmaceuticals
|
|
2011
|
|
2005
|
Luvata >
|
Metal solutions manufacturing and heat transfer technology
|
1570
|
|
|
2006
|
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) |
Specialty pharmaceuticals
|
|
2012
|
|
2006
|
Permobil |
Powered wheelchairs manufacturer
|
|
2013
|
|
2005
|
Cloetta (merger with Leaf) |
Confectionary producer
|
|
2013
|
|
2004
|
FinnvedenBulten |
Metallic fasteners and automotive components
|
|
2014
|
* 2016 sales for companies still in portfolio; sales at exit for divested companies
Contact information:
Nordic Capital Limited
26 Esplanade, St Helier Jersey JE2 3QA
Tel: +44 1534 605 100
Fax: +44 1534 605 199
For all investor communications: investor@nordiccapital.je
